Finzati - Logo
CNTMF logo

Fluent Corp.

CNTMFDrug Manufacturers - Specialty & Generic
$0.02
+0.00 (+3.77%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$15.41M
Growth
Cash Flow
2/5
Trend
Volatile
Evidence
Weak liquidity · 0.34Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.02
Change3.77%
Shares Out700.55M
Market Cap$15.41M
Enterprise Value$79.41M
52W Range0.02 - 0.09
Beta0.85
P/E-0.21
P/S0.18
P/B-0.19
P/FCF-1.05
EV/Sales0.92

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Weak liquidity · 0.34Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 1/8/2021
Industry: Drug Manufacturers - Specialty & Generic
P/B i: -0.19
Debt / Equity i: -1.73
Operating Margin: -17.57%
Net Margin: -83.63%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -1.73
Current Ratio: 0.34
Quick Ratio: 0.16
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio
🧾

No insider activity

No recent insider transactions available.